Osteoprotegerin in pregnant adolescents differs by race and is related to infant birth weight z-score

Journal of Developmental Origins of Health and Disease

Volumn 2, Issue 5, 2011, Pages 272-279

  Essley, B ^a   McNanley, T ^b   Cooper, B ^b   McIntyre, A ^b   Witter, F ^c   Harris, Z ^c   O'Brien, K ^a  

^a Department of Obstetrics Gynecology   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

birth weight; bone; Key wordsadolescent pregnancy; osteoprotegerin.

Indexed keywords

EID: 84555209492     PISSN: 20401744     EISSN: 20401752     Source Type: Journal    
DOI: 10.1017/S2040174411000511     Document Type: Article

References (43)

1. Center for Disease Control and Prevention. Vital signs: teen pregnancy-United States, 1991-2009. Morb Mortal Wkly Rep. 2011; 60, 414-420.
2. Felice ME, Feinstein RA, Fisher MM, et al. Adolescent pregnancy-current trends and issues: 1998 American Academy of Pediatrics Committee on Adolescence, 1998-1999. Pediatrics. 1999; 103, 516-520.
3. Black AJ, Topping J, Durham B, Farquharson RG, Fraser WD. A detailed assessment of alterations in bone turnover, calcium homeostasis, and bone density in normal pregnancy. J Bone Miner Res. 2000; 15, 557-563. (Pubitemid 30134101)
4. Naylor KE, Iqbal P, Fledelius C, Fraser RB, Eastell R. The effect of pregnancy on bone density and bone turnover. J Bone Miner Res. 2000; 15, 129-137. (Pubitemid 30026940)
5. Cross NA, Hillman LS, Allen SH, Krause GF, Vieira NE. Calcium homeostasis and bone metabolism during pregnancy, lactation, and postweaning: a longitudinal study. Am J Clin Nutr. 1995; 61, 514-523.
6. Kovacs CS. Calcium and bone metabolism in pregnancy and lactation. J Clin Endocrinol Metab. 2001; 86, 2344-2348. (Pubitemid 32545674)
7. Kolthoff N, Eiken P, Kristensen B, Nielsen SP. Bone mineral changes during pregnancy and lactation: a longitudinal cohort study. Clin Sci (Lond). 1998; 94, 405-412. (Pubitemid 28176625)
8. Sowers M, Wallace RB, Lemke JH. Correlates of forearm bone mass among women during maximal bone mineralization. Prev Med. 1985; 14, 585-596. (Pubitemid 16191238)
9. Sowers MF, Scholl T, Harris L, Jannausch M. Bone loss in adolescent and adult pregnant women. Obstet Gynecol. 2000; 96, 189-193. (Pubitemid 30447337)
10. Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 1997; 89, 309-319. (Pubitemid 27199902)
11. Hofbauer LC, Heufelder AE. Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology. J Mol Med. 2001; 79, 243-253. (Pubitemid 32646379)
12. Hong JS, Santolaya-Forgas J, Romero R, et al. Maternal plasma osteoprotegerin concentration in normal pregnancy. Am J Obstet Gynecol. 2005; 193, 1011-1015. (Pubitemid 41285486)
13. Naylor KE, Rogers A, Fraser RB, et al. Serum osteoprotegerin as a determinant of bone metabolism in a longitudinal study of human pregnancy and lactation. J Clin Endocrinol Metab. 2003; 88, 5361-5365. (Pubitemid 37452739)
14. Uemura H, Yasui T, Kiyokawa M, et al. Serum osteoprotegerin/ osteoclastogenesis-inhibitory factor during pregnancy and lactation and the relationship with calcium-regulating hormones and bone turnover markers. J Endocrinol. 2002; 174, 353-359. (Pubitemid 34965775)
15. Barker DJ. The origins of the developmental origins theory. J Intern Med. 2007; 261, 412-417. (Pubitemid 46587729)
16. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med. 2008; 359, 61-73.
17. Cooper C, Westlake S, Harvey N, et al. Review: developmental origins of osteoporotic fracture. Osteoporos Int. 2006; 17, 337-347.
18. Schlussel MM, Dos SV, Kac G. Birth weight and adult bone mass: a systematic literature review. Osteoporos Int. 2010; 21, 1981-1991.
19. Kramer MS, Platt RW, Wen SW, et al. A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics. 2001; 108, E35-E42.
20. Gundberg CM, Cole DE, Lian JB, Reade TM, Gallop PM. Serum osteocalcin in the treatment of inherited rickets with 1,25-dihydroxyvitamin D3. J Clin Endocrinol Metab. 1983; 56, 1063-1067. (Pubitemid 13135191)
21. Andreasyan K, Ponsonby AL, Dwyer T, et al. Higher maternal dietary protein intake in late pregnancy is associated with a lower infant ponderal index at birth. Eur J Clin Nutr. 2007; 61, 498-508. (Pubitemid 46605221)
22. Lonergan M, Aponso D, Marvin KW, et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptors, and the soluble receptor osteoprotegerin in human gestational membranes and amniotic fluid during pregnancy and labor at term and preterm. J Clin Endocrinol Metab. 2003; 88, 3835-3844. (Pubitemid 37034536)
23. Briana DD, Boutsikou M, Baka S, et al. Circulating osteoprotegerin and sRANKL concentrations in the perinatal period at term. The impact of intrauterine growth restriction. Neonatology. 2009; 96, 132-136.
24. Dimitri P, Wales JK, Bishop N. Adipokines, bone-derived factors and bone turnover in obese children; evidence for altered fat-bone signalling resulting in reduced bone mass. Bone. 2011; 48, 189-196.
25. Specker B. Nutrition influences bone development from infancy through toddler years. J Nutr. 2004; 134, 691S-695S. (Pubitemid 38298518)
26. Namgung R, Tsang RC. Factors affecting newborn bone mineral content: in utero effects on newborn bone mineralization. Proc Nutr Soc. 2000; 59, 55-63. (Pubitemid 30316606)
27. Raman L, Rajalakshmi K, Krishnamachari KA, Sastry JG. Effect of calcium supplementation to undernourished mothers during pregnancy on the bone density of the bone density of the neonates. Am J Clin Nutr. 1978; 31, 466-469. (Pubitemid 8300941)
28. Viljakainen HT, Korhonen T, Hytinantti T, et al. Maternal vitamin D status affects bone growth in early childhood-a prospective cohort study. Osteoporos Int. 2011; 22, 883-891.
29. Javaid MK, Crozier SR, Harvey NC, et al. Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study. Lancet. 2006; 367, 36-43. (Pubitemid 43038668)
30. Dennison EM, Arden NK, Keen RW, et al. Birthweight, vitamin D receptor genotype and the programming of osteoporosis. Paediatr Perinat Epidemiol. 2001; 15, 211-219. (Pubitemid 32737952)
31. Antoniades L, MacGregor AJ, Andrew T, Spector TD. Association of birth weight with osteoporosis and osteoarthritis in adult twins. Rheumatology (Oxford). 2003; 42, 791-796. (Pubitemid 37220913)
32. Dai Y, Shen L. Relationships between serum osteoprotegerin, matrix metalloproteinase-2 levels and bone metabolism in postmenopausal women. Chin Med J (Engl). 2007; 120, 2017-2021. (Pubitemid 350237810)
33. Jiang LS, Zhang ZM, Jiang SD, Chen WH, Dai LY. Differential bone metabolism between postmenopausal women with osteoarthritis and osteoporosis. J Bone Miner Res. 2008; 23, 475-483.
34. Ohwada R, Hotta M, Sato K, Shibasaki T, Takano K. The relationship between serum levels of estradiol and osteoprotegerin in patients with anorexia nervosa. Endocr J. 2007; 54, 953-959. (Pubitemid 351346779)
35. Hofbauer LC, Khosla S, Dunstan CR, et al. Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology. 1999; 140, 4367-4370. (Pubitemid 30647136)
36. Li Q, Yu K, Tian X, et al. 17beta-estradiol overcomes human myeloma RPMI8226 cell suppression of growth, ALP activity, and mineralization in rat osteoblasts and improves RANKL/OPG balance in vitro. Leuk Res. 2009; 33, 1266-1271.
37. Looker AC, Melton III LJ, Harris T, et al. Age, gender, and race/ethnic differences in total body and subregional bone density. Osteoporos Int. 2009; 20, 1141-1149.
38. Emery JG, McDonnell P, Burke MB, et al. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J Biol Chem. 1998; 273, 14363-14367. (Pubitemid 28319153)
39. Vitovski S, Phillips JS, Sayers J, Croucher PI. Investigating the interaction between osteoprotegerin and receptor activator of NF-kappaB or tumor necrosis factor-related apoptosis-inducing ligand: evidence for a pivotal role for osteoprotegerin in regulating two distinct pathways. J Biol Chem. 2007; 282, 31601-31609. (Pubitemid 350044899)
40. Collin-Osdoby P, Rothe L, Anderson F, et al. Receptor activator of NF-kappa B and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis. J Biol Chem. 2001; 276, 20659-20672.
41. Corallini F, Celeghini C, Rimondi E, et al. TRAIL down-regulates the release of osteoprotegerin (OPG) by primary stromal cells. J Cell Physiol. 2011; 226, 2279-2286.
42. Anum EA, Springel EH, Shriver MD, Strauss III JF. Genetic contributions to disparities in preterm birth. Pediatr Res. 2009; 65, 1-9.
43. Velez DR, Fortunato SJ, Morgan N, et al. Patterns of cytokine profiles differ with pregnancy outcome and ethnicity. Hum Reprod. 2008; 23, 1902-1909. (Pubitemid 352020008)